Reset Treatment and Recovery Support Service - Tower Hamlets

Updated 23 March 2026

Reset Treatment and Recovery Support Service – Tower Hamlets is part of the larger Change Grow Live provider who deliver a not-for-profit drug and alcohol treatment service nationally. The service provides specialist community treatment and recovery support for adults affected by substance misuse who live in Tower Hamlets. The service provides treatment support service from a main site on Whitechapel Road and a satellite site on Johnson Street.

Reset Treatment and Recovery Support Service – Tower Hamlets offer a range of services including initial advice; assessment and harm reduction services including needle exchange; prescribed medicines for alcohol and opiate detoxification and stabilisation; naloxone dispensing; one-to-one key working sessions and doctor and nurse clinics which include health checks, blood borne virus and hepatitis C testing.

The service works in partnership across Tower Hamlets with other agencies, including NHS services, social services, probation services, GPs and pharmacies.

The service is registered for the following regulated activity: Treatment of disease, disorder or injury.

As a result of this inspection, we rated each of the five key questions and the service overall as good.

The service continues to demonstrate good practice in several areas. People described staff as kind, respectful and supportive, and said the service had a positive impact on their lives. They valued flexible appointments, tailored interventions and practical help such as housing and health support. Staff training compliance for safeguarding and basic life support is high, and leaders have strengthened oversight of contact and review arrangements. Policies and pathways support safe care, and audits showed high compliance with prescription security and benzodiazepine prescribing standards. Infection prevention and control audits were strong, and governance systems supported incident reporting and shared learning.

However, there were some areas where good practise improvements could be made. For example the use of patient group directives needed strengthening. Some staff had high caseloads. Some rooms were not sufficiently sound proofed. At the time of our inspection, the service was not meeting its own targets for the number of people successfully completing programmes.

Updated 16 July 2025

Reset Treatment and Recovery Support Service – Tower Hamlets is part of the larger Change Grow Live provider who deliver a not-for-profit drug and alcohol treatment service nationally. The service provides specialist community treatment and recovery support for adults affected by substance misuse who live in Tower Hamlets. The service provides treatment support service from a main site on Whitechapel Road and a satellite site on Johnson Street.

Reset Treatment and Recovery Support Service – Tower Hamlets offer a range of services including initial advice; assessment and harm reduction services including needle exchange; prescribed medicines for alcohol and opiate detoxification and stabilisation; naloxone dispensing; one-to-one key working sessions and doctor and nurse clinics which include health checks, blood borne virus and hepatitis C testing.

The service works in partnership across Tower Hamlets with other agencies, including NHS services, social services, probation services, GPs and pharmacies.

The service is registered for the following regulated activity: Treatment of disease, disorder or injury.

As a result of this inspection, we rated each of the five key questions and the service overall as good.

The service continues to demonstrate good practice in several areas. People described staff as kind, respectful and supportive, and said the service had a positive impact on their lives. They valued flexible appointments, tailored interventions and practical help such as housing and health support. Staff training compliance for safeguarding and basic life support is high, and leaders have strengthened oversight of contact and review arrangements. Policies and pathways support safe care, and audits showed high compliance with prescription security and benzodiazepine prescribing standards. Infection prevention and control audits were strong, and governance systems supported incident reporting and shared learning.

However, there were some areas where good practise improvements could be made. For example the use of patient group directives needed strengthening. Some staff had high caseloads. Some rooms were not sufficiently sound proofed. At the time of our inspection, the service was not meeting its own targets for the number of people successfully completing programmes.